Date: Thu, 18 Dec 1997 20:08:10 GMT
Server: Apache/1.1.3
Content-type: text/html
Content-length: 22202
Last-modified: Tue, 16 Dec 1997 19:47:47 GMT

<HTML>
<HEAD>
   <META HTTP-EQUIV="Content-Type" CONTENT="text/html; charset=iso-8859-1">
   <META NAME="Author" CONTENT="Lee Rickles">
   <META NAME="GENERATOR" CONTENT="Mozilla/4.01 [en] (Win95; I) [Netscape]">
   <META NAME="resource-type" CONTENT="document">
   <META NAME="description" CONTENT="Non-Invasive Monitoring Systems - description     of the company, our current activities and future directions.">
   <META NAME="keywords" CONTENT="NIMS Non Invasive Monitoring Systems Respiratory     Inductive Plethysmography Cardio Monitor Measure Respiration Volume">
   <META NAME="distribution" CONTENT="global">
   <TITLE>Non-Invasive Monitoring Systems, Inc.</TITLE>
</HEAD>
<BODY BACKGROUND="Graphics/web1.JPG" NOSAVE>
&nbsp;
<CENTER><IMG SRC="Graphics/nimsblue.GIF" NOSAVE HEIGHT=91 WIDTH=246></CENTER>

<CENTER><FONT FACE="Arial,Helvetica">Non-Invasive Monitoring Systems, Inc.
(Nims)</FONT></CENTER>

<CENTER>
<H2>
<B><FONT FACE="Photina"><FONT COLOR="#666666">Corporate Information</FONT></FONT></B></H2></CENTER>

<UL>
<UL>
<UL>
<UL>
<LI>
<FONT FACE="Times New Roman,Times"><FONT SIZE=+1>&nbsp;&nbsp;&nbsp; Research
and Product Development Company</FONT></FONT></LI>

<LI>
<FONT FACE="Times New Roman,Times"><FONT SIZE=+1>&nbsp;&nbsp;&nbsp; Traded
as NIMU OTC</FONT></FONT></LI>
</UL>
</UL>
&nbsp;</UL>
<B><FONT FACE="Photina"><FONT COLOR="#666666">Management:</FONT></FONT></B>
<BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT FACE="Times New Roman,Times">Marvin A. Sackner, M.D.,&nbsp; CEO</FONT>
<BR><FONT FACE="Times New Roman,Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Mike Inman, Vice President, Research and Development</FONT>
<BR><FONT FACE="Times New Roman,Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Lee J. Rickles, COO</FONT>
<BR>&nbsp;
<BR><B><FONT FACE="Photina"><FONT COLOR="#666666">Location:</FONT></FONT></B>
<BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT FACE="Times New Roman,Times">1840 West Avenue</FONT>
<BR><FONT FACE="Times New Roman,Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Miami Beach, Florida, 33139 USA</FONT>
<BR><FONT FACE="Times New Roman,Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Tel.&nbsp; 305 534-3694&nbsp;&nbsp;&nbsp; Fax&nbsp; 305 534-9368</FONT>

<P><B><FONT FACE="Photina"><FONT COLOR="#666666">Research &amp; Development
Contractual Arrangements or Licenser Inquiries:</FONT></FONT></B>
<BR><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>
<FONT FACE="Times New Roman,Times">Lee Rickles, COO</FONT>
<BR><FONT FACE="Times New Roman,Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1840 West Avenue, Miami Beach, FL&nbsp; 33139 USA</FONT>
<BR><FONT FACE="Times New Roman,Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Tel. 305-534-3694&nbsp;&nbsp; Fax 305 534-9368</FONT>
<BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT FACE="Times New Roman,Times">E-Mail </FONT><A HREF="mailto:nims@ctech.net">nims@ctech.net</A>
<BR>&nbsp;
<CENTER><B><FONT FACE="Photina"><FONT COLOR="#666666"><FONT SIZE=+2>Press
Releases</FONT></FONT></FONT></B></CENTER>

<CENTER>&nbsp;</CENTER>

<UL>
<UL>
<UL>
<LI>
<B><FONT FACE="Photina"><FONT COLOR="#000000">Tuesday December 15, 1997&nbsp;&nbsp;
NON-INVASIVE MONITORING SYSTEMS REPORTS 1st QUARTER RESULTS</FONT></FONT></B></LI>

<LI>
<B><FONT FACE="Photina"><FONT COLOR="#000000">Tuesday October 28, 1997&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
NON-INVASIVE MONITORING SYSTEMS REPORTS PROFITABLE YEAR END RESULTS AS
RESEARCH AND DEVELOPMENT CORP</FONT><FONT COLOR="#666666">.</FONT></FONT></B></LI>
</UL>
<B><FONT FACE="Photina"><FONT COLOR="#666666"></FONT></FONT></B>&nbsp;</UL>
</UL>

<HR SIZE=5 WIDTH="100%">
<BR><B><FONT FACE="Photina"><FONT COLOR="#666666">Consolidated Financial
Summary Nims, Inc.:</FONT></FONT></B>
<BR><B><FONT FACE="Photina"><FONT COLOR="#666666">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT COLOR="#000000">First Quarter ended October 31:</FONT></FONT></B>

<P><FONT COLOR="#000000"><FONT FACE="Photina">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT FACE="Times New Roman,Times"><U>1997</U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>1996</U></FONT></FONT>
<BR><FONT FACE="Times New Roman,Times"><FONT COLOR="#000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Total Revenue&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
$&nbsp;&nbsp; 50,038&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
$ 283,901</FONT></FONT>
<BR><FONT FACE="Times New Roman,Times"><FONT COLOR="#000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Net (loss) Income&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(168,320)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(30,183)</FONT></FONT>
<BR><FONT FACE="Times New Roman,Times"><FONT COLOR="#000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Income (loss) per share&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(0.014)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(0.002)</FONT></FONT>
<BR><FONT FACE="Times New Roman,Times"><FONT COLOR="#000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Weighted average number</FONT></FONT>
<BR><FONT FACE="Times New Roman,Times"><FONT COLOR="#000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
of shares outstanding&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
12,439,729&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
12,439,729</FONT></FONT>

<P>
<HR SIZE=5 WIDTH="100%">
<BR><B><FONT FACE="Times New Roman,Times"><FONT SIZE=+1>NON-INVASIVE MONITORING
SYSTEMS REPORTS 1st QUARTER RESULTS</FONT></FONT></B>

<P><FONT FACE="Times New Roman,Times">MIAMI BEACH, FLORIDA - DECEMBER 15,
199<B>7 - </B>Non-Invasive Monitoring Systems, Inc. (Nims) (OTC:NIMU) announced
results for the first three months ended October 31, 1997.</FONT>

<P><FONT FACE="Times New Roman,Times">Total revenue for the first quarter
ended October 31, 1997, was approximately $50,038 as compared to $238,
901 for the first quarter of fiscal year 1997.&nbsp; For the three months
ended October 31, 1997, the Company reported a net loss of approximately
$168,320 as compared to a net loss of approximately $30,183 for the first
quarter of fiscal 1997.&nbsp; The decrease in revenue for the three month
period was the result of decreased sales to SensorMedics Corporation, the
principal distributor of the Comapny's products.</FONT>

<P><FONT FACE="Times New Roman,Times">Non-Invasive Monitoring Systems,
Inc. is in the business of developing hardware and software devices based
upon sensors placed externally on the body surface.&nbsp; These devices
provide diagnostic information regarding cardiorespiratory and sleep disorders
in infants, children and adults; alarms are sounded for adverse cardiac
and respiratory events in critically ill patients.&nbsp; In addition, Nims
also is developing non-invasive devices for treatment of cardiorespiratory
disorders.&nbsp; The Company's proudcts are available for license to others
for marketing and manufacture.</FONT>

<P><FONT FACE="Times New Roman,Times">In line with its new direction for
developing non-invasive devices for treatment of cardiorespiratory disorders,
the Company devised and is testing a device that provides non-inavsive
motion ventilation, i.e., a powered, moving platform under computer control
produces passive movements of the body that in turn provides ventilation.&nbsp;
This method, for which a patent has been applied, does not require connection
to the airway for imposed, cycling, positive pressures as is the case for
conventional mechanical ventilators.&nbsp; Experiments indicate that this
new method provides adequate ventilation as measured by arterial blood
gases when the respiratory muscles are paralyzed in the presence of both
normal and markedly diseased lungs.&nbsp; Furthermore, the method also
supports the circulation during cardiac arrest.</FONT>

<P><FONT FACE="Times New Roman,Times">This press release contains, in addition
to historical information forward-looking statements regarding Non-Invasive
Monitoring Systems, Inc. (Nims) which represent Nims expectation or beliefs
including, but not limited to, statements concerning industry performance,
the Company's operations, performance, financial condition, business strategies,
margins, and sales information.&nbsp; For this purpose, any statements
contained in this Release that are not statements of historical fact may
be deemed to be forward-looking statements.&nbsp; These statements by their
nature involve substantial risks and uncertainties, certain of which are
beyond the Company's control, and actual results could differ materially
depending on a variety of important factors, including those described
in this Release and the Company's filings with the Securities and Exchange
Commission.</FONT>

<P>
<HR SIZE=5 WIDTH="100%">
<BR><B><FONT FACE="Photina"><FONT COLOR="#666666">Consolidated Financial
Summary Nims, Inc.:</FONT></FONT></B>
<BR><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B><FONT FACE="Times New Roman,Times">Fiscal Year Ended July 31:</FONT></B>
<BR><FONT FACE="Times New Roman,Times">&nbsp;</FONT>
<BR><FONT FACE="Times New Roman,Times"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B><U>1997&nbsp;</U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>1996</U></FONT>
<BR><FONT FACE="Times New Roman,Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Total Revenue&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
$ 1,351,982&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $ 1,722,632</FONT>
<BR><FONT FACE="Times New Roman,Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Net Income (loss)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
162,903&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(394,140)</FONT>
<BR><FONT FACE="Times New Roman,Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Income (loss) per share&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
0.01&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(0.03)</FONT>
<BR><FONT FACE="Times New Roman,Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Weighted average number</FONT>
<BR><FONT FACE="Times New Roman,Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
of shares outstanding&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
12,439,730&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
12,439,729</FONT>

<P>
<HR SIZE=5 WIDTH="100%">

<P><B><FONT FACE="Times New Roman,Times"><FONT SIZE=+1>NON-INVASIVE MONITORING
SYSTEMS REPORTS PROFITABLE YEAR END RESULTS AS RESEARCH AND DEVELOPMENT
CORP.</FONT></FONT></B>

<P><FONT FACE="Times New Roman,Times">MIAMI BEACH, FLORIDA - OCTOBER 28,
1997 - Non-Invasive Monitoring Systems, Inc. (Nims) (OTC:NIMU) announced
results for the year ended July 31, 1997.</FONT>

<P><FONT FACE="Times New Roman,Times">For the year ended July 31, 1997,
Nims reported income of approximately $163,000 compared to a net loss of
approximately $394,000 for the year ended July 31, 1996.&nbsp; For fiscal
1997 total revenue was approximately $1,352,000 as compared to approximately
$1,723,000 in fiscal 1996.&nbsp; The revenue for the year ended July 31,
1997 was primarily generated from a Joint Manufacturing and Marketing Agreement
between Nims and SensorMedics Corporation (SMC) which was entered into
in December of 1996.&nbsp; This agreement between Nims and SMC granted
SMC exclusive rights to manufacture and marketing Nims' disposable Respiband
transducers along with non-exclusive rights to manufacture and market certain
other Nims products.&nbsp; Accordingly the SMC Agreement has allowed Nims
to focus its efforts on the Company's strength.&nbsp; In this regard during
fiscal 1997, pursuant to the agreement with SMC Nims developed a new diagnostic
sleep recorder to be manufactured and marketed exclusively by SMC.&nbsp;
Nims has also undertaken additional product development efforts.</FONT>

<P><FONT FACE="Times New Roman,Times">Non-Invasive Monitoring Systems,
Inc. develops hardware devices based upon sensors placed externally on
the body surface which provide diagnostic information through proprietary
software for cardiorespiratory and sleep disorders in infants, children
and adults.&nbsp; These devices can also sound alarms for adverse cardiac
and respiratory events in critically ill patients.&nbsp; In addition, Nims
is developing non-invasive devices for treatment of cardiorespiratory disorders.&nbsp;
The Company licenses its products to third parties for marketing and manufacture.</FONT>

<P><FONT FACE="Times New Roman,Times">Apart from SMC activities, Nims is
developing non-invasive devices for treatment of cardiorespiratory disorders.&nbsp;
The Company has devised and is testing a device that provides non-invasive
motion ventilation, i.e., a powered, moving platform under computer control
produces passive movements of the body that give rise to ventilation.&nbsp;
This method, for which a patent has been applied, does not require connection
to the airway for imposed positive pressures as is the case for conventional
mechanical ventilators.&nbsp; Initial experiments indicate that this new
method provides adequate ventilation as measured by arterial blood gases
when the respiratory muscles are paralyzed.</FONT>

<P><FONT FACE="Times New Roman,Times">This press release contains, in addition
to historical information forward-looking statements regarding Non-Invasive
Monitoring Systems, Inc., (Nims) which represent Nims expectations or beliefs
including, but not limited to, statements concerning industry performance,
the Company's operations, performance, financial condition, business strategies,
margins, and sales information.&nbsp; For this purpose, any statements
contained in this Release that are not statements of historical fact may
be deemed to be forward-looking statements.&nbsp; These statements by their
nature involve substantial risks and uncertainties, certain of which are
beyond the Company's control, and actual results could differ materially
depending on a variety of important factors, including those described
in this Release and the Company's filings with the Securities and Exchange
Commission.</FONT>

<P><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>
<BR>&nbsp;

<P>&nbsp;
<TABLE BORDER COLS=4 WIDTH="100%" >
<TR>
<TD><FONT FACE="Times New Roman,Times"><A HREF="respitrace.html">Respitrace
Technology</A></FONT></TD>

<TD><FONT FACE="Times New Roman,Times"><A HREF="respitrace.html">Markets
for Nims Technology</A></FONT></TD>

<TD><FONT FACE="Times New Roman,Times"><A HREF="current.html">Nims Positioned
for Current Health Care Dynamics</A></FONT></TD>

<TD><FONT FACE="Times New Roman,Times"><A HREF="products.html">Current
Products</A></FONT></TD>
</TR>

<TR>
<TD><FONT FACE="Times New Roman,Times"><A HREF="patents.html">Patent /
Proprietary Position 510(k)</A></FONT></TD>

<TD><FONT FACE="Times New Roman,Times"><A HREF="patents.html">Patented
Products Documented in Medical Literature not yet submitted to FDA&nbsp;</A></FONT></TD>

<TD><FONT FACE="Times New Roman,Times"><A HREF="business.html">Current
Business Directions</A></FONT></TD>

<TD><FONT FACE="Times New Roman,Times"><A HREF="financials.html">Corporate
Information</A></FONT>&nbsp;
<BR><FONT FACE="Times New Roman,Times"><A HREF="financials.html">Current
Press Releases</A></FONT></TD>
</TR>
</TABLE>

<CENTER><FONT SIZE=-1>All contents Copyright 1997 Nims, Inc. All rights
reserved.</FONT></CENTER>

<CENTER><FONT SIZE=-1>Respitrace, Respitrace Plus, Respiband are registered
trademarks of Nims, Inc.</FONT></CENTER>

<CENTER>&nbsp;</CENTER>

<CENTER>&nbsp;</CENTER>

<CENTER>&nbsp;</CENTER>
</UL>

</BODY>
</HTML>
